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Purpose: Avulsed tooth can be completely recovered, if sound periodontal ligament (PDL) of tooth is maintained. Although a 
lot of storage solutions have been explored for the better storage of avulsed tooth, there is a shortcoming that the preservation 
time is much short. On the other hand, there has been studies that (-)-epigallocatechin-3-gallate (EGCG), the most abundant 
polyphenol in green tea, which is related to the anti inflammatory, antioxygenic, and antibacterial effects, allows the successful 
preservations of tissues and cells. This study evaluated the effect of EGCG on avulsed-teeth preservation of Beagle dogs for a 
period of time. 
Methods: The atraumatically extracted teeth of Beagle dogs were washed and preserved with 0/10/100 µM of EGCG at the 
time of immediate, period 1 (4 days in EGCG-contained media and additional 1 day in EGCG-free media), period 2 (8 days in 
EGCG-contained media and additional 2 days in EGCG-free media) and period 3 (12 days in EGCG-contained media and ad-
ditional 2 days in EGCG-free media). Then, the cell viabilities of preserved teeth was calculated by dividing optical density (OD) 
of 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay with OD of eosin assay to eliminate the mea-
surement errors caused by the different tissue volumes. 
Results: From the results, the immediately analyzed group presented the highest cell viability, and the rate of living cells on 
teeth surface decreased dependent on the preservation period. However, the 100 µM of EGCG-treated group showed statisti-
cally significant positive cell activity than EGCG-free groups throughout preservation periods. 
Conclusions: Our findings showed that 100 µM EGCG could maintain PDL cell viability of extracted tooth. These results 
suggest that although EGCG could not be a perfect additive for tooth preservation, it is able to postpone the period of tooth 
storage. However, further in-depth studies are required for more plausible use of EGCG.
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INTRODUCTION
Tooth avulsion is considered a severe form of dental trau-
ma because the involved tooth is completely displaced from 
the alveolar socket, thus causing damage to the periodonti-
um of the tooth [1]. The established vascular system of the 
periodontium is destroyed, the immediate vacant space is 
filled mostly with blood clots that further disconnect the 
avulsed tooth from the socket, and thus the supply of blood 
and nutrition to it is insufficient [2]. More seriously, the peri-
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odontal ligament (PDL) may be ruptured and damaged by 
the traumatic pressure, and may become infected. Such dam-
age to the PDL can cause root resorption, tooth-bone ankylo-
sis, or tissue necrosis, and these outcomes end in transplanta-
tion failure [3,4]. The presence of healthy PDL tissues and 
cells is known to be a pivotal factor for both successful tooth 
transplantation and avulsed tooth replantation [3,5]. Many 
studies have therefore been performed to determine the 
most appropriate methods of preserving healthier PDL tis-
sues, and to develop a socket-preparation method to promote 
more effective tooth replantations.
Milk, Hanks’ balanced salt solution, University of Wiscon-
sin solution, and Euro-Collins solution all have favorable pres-
ervation effects for up to 24 hours after extraction [6-10]. Mean-
while, Nethander et al. [2] introduced the two-stage surgical 
technique for tooth transplantation, in which they left the re-
cipient socket to heal 14 days before implanting the tooth; 
this delayed tooth transplantation technique has yielded out-
standing results, with lower rates of resorption and ankylosis 
being found in many studies [2,11-14]. However, the preserva-
tion period of the suggested storage solutions was found to 
be insufficient, since they were unable to maintain PDL cell 
viability for 2 weeks, and inflammatory or replacement (an-
kylosis) resorption still occurred in the delayed tooth trans-
plantation technique [3,11,15]. Furthermore, when patients 
suffer from more serious injuries than dental avulsion, they 
may not receive the most appropriate dental treatments in 
some cases, even leaving the exfoliated tooth for a few days 
until replantation. Therefore, it seems to be essential to de-
velop storage agents that can maintain the viability and func-
tion of PDL tissues for a much longer period, and, if it could, 
can control the inflammatory reactions or infections at the 
recipient site.
(-)-Epigallocatechin-3-gallate (EGCG), a major polyphenol 
of green tea, reportedly exerts various biological effects in-
cluding cytostatic properties for preserving cells, antibacterial 
and anti-inflammatory reactions, and antioxidant and anti-
carcinogenic effects [16-18]. In particular, it has been demon-
strated that EGCG is effective in preserving mammalian cells 
and tissues, such as blood vessels, corneas, nerves, islet cells, 
myocardium, and hematopoietic stem cells [19-22], and their 
excellent histological and biomechanical recovery was also 
demonstrated for up to 3 months after storage in EGCG [22]. 
It was also reported that the high cell viability of guinea pig 
incisor PDL cells could be maintained using EGCG [23], and 
we have confirmed the ability of EGCG to control the viabili-
ty of human PDL (hPDL) fibroblasts [24]. In addition, EGCG 
was reported to improve the periodontal condition in peri-
odontitis and periapical lesions due to its bactericidal effect 
against periodontal pathogens [25,26], and to inhibit the pro-
duction of related cytokines and their inflammatory path-
ways, such as carbon tetrachloride, tumor necrosis factor-α, 
nuclear factor-κB, cycolooxygenase-2, and inducible nitric 
oxide synthase [27-30]. In addition, it was demonstrated that 
EGCG concentration-dependently inhibits the formation of 
bone-resorbing cells (i.e., osteoclasts and osteoclast-like mul-
tinucleated cells) and induces their apoptotic cell death 
[31,32].
Given the protective potential of EGCG treatment against 
destruction of the periodontium, it may be used to promote 
favorable tooth transplantation with lower rates of infection 
and less root resorption and ankylosis, which are major rea-
sons for failure of the procedure. If the preservative and ther-
apeutic properties of EGCG can also be applied in other den-
tal treatments, patients may experience better rehabilitative 
treatment. This prompted the present study to evaluate the 
effect of EGCG on the preservation of teeth extracted from 
Beagle dogs and the maintenance of their PDL cell viability.
MATERIALS AND METHODS
Animals
Five male, 18- to 24-month-old Beagle dogs (25-30 kg) with 
intact dentition and healthy periodontia were used in the ex-
periments. Animal selection, management, surgical protocol, 
and preparation followed routines approved by the Institu-
tional Animal Care and Use Committee, Yonsei Medical 
Center, Seoul, Korea.
Tooth extraction
Supragingival scaling and plaque control were performed 
for all dogs 5 days before tooth extraction. Surgery was per-
formed under general anesthesia induced by intravenous in-
jection of Zoletil50 (5 mg/kg; Yuhan, Seoul, Korea) and Rom-
pun (0.2 mg/kg; Bayer Korea, Seoul, Korea) followed by the 
administration of inhaled enflurane. Local infiltration anes-
thesia (2% lidocaine with HCl epinephrine, 1:100,000; Hu-
ons Co., Seoul, Korea) was used to reduce hemorrhage in the 
surgical areas. In both quadrants of the mandible, the first to 
third premolars (P1, P2, and P3) were the focus of this study. 
After an intrasulcular incision, the teeth were carefully hemi-
sectioned with a high-speed bur and the teeth were extracted 
as atraumatically as possible using a forceps to protect the 
sound periodontal ligament tissues. Thirty teeth (P1, P2, and 
P3) were extracted from five Beagle dogs (Fig. 1A). Of these, 
50 uncontaminated and undamaged hemisectioned-teeth 
were used fot the analysis (Fig. 1B). 
Preservation of the tooth with EGCG
A modified version of the tooth-preparation protocol of 
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cells with the most similar morphology and greatest viability 
were obtained after tooth preservation in media containing 
250 µg/mL EGCG (i.e., 545.4 µM). The extracted teeth were 
divided into the following four groups: immediate, period 1, 
period 2, and period 3 (Table 1). The extracted teeth in the im-
mediate (control) group were subjected to the 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 
immediately after washing. Those in the period-1 group were 
subjected to the MTT assay after preservation with 0, 10, or 
100 µM EGCG medium for 4 days, and then with EGCG-free 
medium for a further day. Those in the period-2 group were 
analyzed after preservation in the various concentrations of 
EGCG media for 8 days and in EGCG-free medium for 2 days. 
Finally, those in the period-3 group were analyzed after treat-
ment for 12 days in the various EGCG media and in EGCG-
free media for a further 2 days. According to Han et al. [34], 
EGCG conjugated to fluorescein-4-tisothiocyanate was ob-
served at the membrane, cytoplasm, and nuclei of L929 fi-
broblast cells at 2 days after treatment, with the intensity in-
creasing with increasing treatment time but beginning to re-
verse 2 days later. Therefore, in the present study we added 
EGCG-free periods after preservation in EGCG medium to 
analyze the recovered cell viability on the root surfaces of the 
teeth in each group.
Evaluation of PDL cell viability (MTT/eosin assay)
The PDL cell viability on each root surface was analyzed us-
ing a modification of the method reported by Kim et al. [35]. 
MTT solution (Amresco Inc., Solon, OH, USA) was added to 
each well of a 24-well plate at a final concentration of 0.5 mg/
mL. Each treated tooth was immersed in a well. After incu-
Table 1. Tooth preservation in the medium with or without EGCG (n=5).
Application
period
EGCG concentration 
(µM)
Experiment day
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Immediate 0 Assay
Period 1 0
10 + + + + - Assay
100
Period 2 0
10 + + + + + + + + - - Assay
100
Period 3 0
10 + + + + + + + + + + + + - - Assay
100
EGCG: (-)-epigallocatechin-3-gallate.
Immediate: performed assay immediately after extraction and washing of the teeth, Period 1: preserved in the media with EGCG for 4 days and without EGCG for 1 
additional day, Period 2: preserved in the media with EGCG for 8 days and without EGCG for 2 additional days, Period 3: preserved in the media with EGCG for 12 days 
and without EGCG for 2 additional days, Assay: performance of the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, +: 0, 10, or 100 µM EGCG-
containing preservation medium, -: EGCG-free preservation.
Matsumura et al. [23] and Oh et al. [33] was followed. Of the 
60 extracted hemisectioned teeth, 50 uncontaminated and 
undamaged hemisectioned teeth were analyzed. The teeth 
were divided into ten groups containing five teeth each. In 
brief, each tooth was lightly dipped three times in 70% alco-
hol and washed in phosphate-buffered solution (PBS). The 
coronal parts of the teeth were then soaked in povidone-io-
dine for 20 seconds and washed a further three times in PBS. 
After rinsing with α-MEM, each tooth was preserved in 3 mL 
of medium supplemented with 10% fetal bovine serum (FBS; 
Invitrogen Co., Carisbad, CA, USA), 100 U/mL penicillin, 100 
mg/mL streptomycin 0% FBS (Invitrogen Co.), 0.3 µg/mL 
Fungizone 0% FBS (Invitrogen Co.), 22.5% Ham’s nutrient 
mixture F-12 0% FBS (Invitrogen Co.), and 66.5% DMEM 0% 
FBS (Invitrogen Co.) in 24-well plates (Fig. 1B). The treatment 
concentrations of EGCG selected were 0, 10, and 100 µM 
based on our previous study [24] finding that the cell viability 
of cultured hPDL fibroblasts was highest in 10 µM EGCG 
media. Moreover, Matsumura et al. [23] demonstrated that 
Figure 1. Extraction and preservation of teeth from Beagle dogs. 
The teeth of Beagle dogs were extracted atraumatically (A) and pre-
served in 24-well plates in storage media containing (-)-epigallocat-
echin-3-gallate at various concentrations (B).
A B
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bating the wells for 3 hours at 37°C, the supernatant of each 
well was removed and replaced by 1 mL of dimethyl sulfox-
ide (Amresco Inc.). The plate was incubated for a further 30 
minutes. After removing the teeth, the optical density (OD) 
of each well was measured using a microplate reader (Bio-
Rad Laboratories Inc., Hercules, CA, USA) at a wavelength of 
570 nm. Each OD ratio of the MTT assay was divided by the 
PDL tissue area of each root surface in order to eliminate the 
measurement errors caused by the different tissue volumes. 
To obtain the relative tissue volume, each tooth that had al-
ready been used for the MTT assay was stained again with 
eosin (Sigma-Aldrich Co., St. Louis, MO, USA) for 12 hours, 
and then treated with ethanol and 1% acidified alcohol for 
another 12 hours to extract the stained eosin. The OD of each 
of the extracts was then measured at 450 nm as described 
above. Each MTT value was divided by the relative tissue 
volume to obtain the final value.
Statistical analysis
Data from in vitro experiments were subjected to analysis 
of variance for multiple comparisons and then the Fisher 
protected least-significant-difference test. The level of statis-
tical significance value was set at P<0.05.
RESULTS
MTT/eosin assay
The cell viability was highest in the control group, and the 
number of living cells on the root surface decreased in a 
preservation-period-dependent manner for all treatment 
groups (Fig. 2). For the group treated with 0 and 10 µM 
EGCG, there was a statistically significant decrease in the 
number of living cells from immediate to period 1, although 
it generally decreased over the whole period. Similarly, 
though it did not show clear significant differences, the 100 
µM EGCG group exhibited a decrease in cell viability from 
immediate to period 1. Interestingly, however, the cell viabil-
ity of the 100 µM EGCG group increased and was recovered 
from period 2 to period 3. On the other hand, all the cell via-
bilities of the EGCG treated groups were higher than those of 
the untreated group, and the differences between 100 and 0 
µM EGCG groups were statistically significant throughout all 
of the periods. A similar outcome was found between 100 
and 10 µM EGCG groups (n=5, P<0.05).
The cell viabilities related to EGCG concentration were 
compared for each period except for the immediate one (Fig. 
3). In all periods, the lowest and highest cell viabilities were 
exhibited by the 0 and 100 µM EGCG groups, respectively. 
There was no significant difference among the three groups 
of immediate, and also between the 0 and 10 µM, and the 10 
and 100 µM EGCG groups in all periods. More importantly, 
the cell viability was markedly higher in the 100 µM EGCG 
group than in the untreated (0 µM EGCG) group (P<0.05). 
Therefore, EGCG at a high concentration appeared to im-
prove the maintenance of cell viability over the controlled 
conditions. 
DISCUSSION 
In this study, we observed improved maintenance of the vi-
ability of Beagle dog tooth cells when they were stored in 
medium containing EGCG, an effect that was somewhat con-
centration-dependent. Extension of the preservation period 
up to 14 days was achieved using 100 µM EGCG, compared 
to that of conventional (non-EGCG-containing) storage solu-
tions, in which it lasts for 24 hours at most [6-10].
To the best of our knowledge, few studies have investigated 
the application of EGCG in tooth preservation. However, the 
efficacy of EGCG as a storage medium has been explored for 
other tissues and cells, such as osteoblasts, fibroblasts, endo-
thelial cells, platelets, blood vessels, nerves, articular cartilage 
of joints, and hematopoietic stem cells [19-22,36,37]. These cells 
were successfully preserved by EGCG treatment for signifi-
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Figure 2. Changes in cell viability of the tooth surface, according to 
the preservation period. The teeth were treated with 0, 10, or 100 
µM (-)-epigallocatechin-3-gallate (EGCG), after which cell-viability 
assays (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) were performed at various points in time: immediate, period 
1 (preservation with EGCG for 4 days and one further day without 
it), period 2 (for 8 days with EGCG and 2 further days without), and 
period 3 (for 12 days with EGCG and 2 further days without). Data 
are mean±SD values. Uppercase letter: comparisons among con-
centrations of EGCG (P<0.05). Lowercase letter: comparisons 
among analysis periods (P<0.05).
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cantly longer periods of up to 3 months, maintaining their 
cell viability, biomechanical properties, structures, and func-
tions [19-22,36,37]. Moreover, in a previous study we explored 
the effect of EGCG on hPDL fibroblasts and concluded that 
EGCG has the potential to control the cell viability of these 
cells. Considering these results, it is thought that the higher 
cell viability of the teeth observed in the present study was 
due to the preservative effects of EGCG, and that tooth pres-
ervation of much longer than 14 days is plausible by using 
EGCG as a storage agent.
The preservative potential of EGCG has been attributed to 
its intrinsic properties, and in particular, its molecular struc-
ture and amphipathic property [20,38]. Because of its pheno-
lic structure, EGCG neutralizes the free radicals of reactive 
oxygen species by chelating with them, which cause hazard 
alterations of cell components, and thus protects cells and 
tissues from oxidative-stress-induced damage [38,39]. Fur-
thermore, since EGCG has both hydrophilic and lipophilic 
properties, it combines easily with the extracellular matrix, 
phospholipid bilayered membranes, and any type of intracel-
lular protein [20], as well as the cytoplasm and nucleus [34]. 
Thereafter, those incorporated EGCGs begin to arrest the cell 
cycle through blockage at specific sites on the cellular mem-
brane or DNA, such as the cyclin genes, which are involved 
directly in cell-cycle regulation [40]. Then, those reactions in-
duce cytostatic activity in the cells or tissues. This activity may 
be related to the mechanism underlying the maintenance of 
cell viability observed in the present study. Thus, the higher 
cell viability of EGCG-treated teeth observed herein may be 
the result of less oxidative damage and the cytostatic effects 
of EGCG.
In our study, the EGCG treatment was followed by addi-
tional EGCG-free incubations. Although EGCG molecules 
can be easily incorporated into cellular proteins or nuclei, 
they become reversibly detached with the progression of time 
in the absence of EGCG, thus initiating the cell cycles of stored 
cells [20,34,40]. In a study, cDNA microarray analysis has re-
vealed that the cell-cycle-related genes of cells are suppressed 
under the influence of EGCG, but once EGCG is removed 
from the medium, the gene expressions are restored to their 
original levels [40]. Over 60% of such alterations were re-
versed 2 days after removal of EGCG, and restored to their 
initial state 8 days after eliminating EGCG [40]. However, the 
cell viability of the tooth surface in the present study was an-
alyzed 1 or 2 days after removing EGCG, not up to 8 days, and 
thus the accomplishment of cellular recovery could not be 
analyzed. Therefore, the recovered cell viabilities of the EGCG-
treated groups may in fact be much higher than shown by 
the present results with longer post-EGCG-free periods.
The promising potential of EGCG has been explored in 
dental parts as well as in the medical fields [16-26,36,37]. EGCG 
has shown to extend the lifespan of dental cells and tissues 
and maintain them in a stable condition [23-24]. Furthermore, 
it was reported to help the recovery from inflammation in 
periodontal and periapical lesions, acting as a bactericide and 
immune suppressor [25-27,30]. Thus, treatment with EGCG 
can be a great therapeutic strategy for tooth transplantation, 
since storage of avulsed teeth in a medium containing EGCG 
will allow sufficient time for the appropriate dental treatment. 
The EGCG subsequently released from the replanted tooth 
into its socket could reduce inflammatory reactions and bac-
terial infections [25-30]. These effects are not limited to the 
replantation of avulsed teeth; they could be applied to autog-
enous tooth transplantation or selected allografting of healthy 
teeth. However, before its clinical application, further studies 
are needed to determine the precise mechanisms underly-
Figure 3. Differences in cell viability according to the concentration of (-)-epigallocatechin-3-gallate (EGCG). 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide assays were performed for the extracted teeth after periods 1 (A), 2 (B), and 3 (C). The teeth were treated 
with 0, 10, or 100 µM EGCG for 4, 8, or 12 days depending on the period. Data are mean±SD values. a) Statistically significant difference be-
tween those teeth treated with 0 and 100 µM EGCG (P<0.1). b) Statistically significant difference between those teeth treated with 0 and 100 
µM EGCG (P<0.05).
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ing the preservative effects of EGCG on teeth and other den-
tal tissues, and more long-term in vivo data of replants with 
EGCG are required.
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